Affiliation:
1. Department of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, Zhejiang, 310058, China; Department of Respiratory Medicine, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang,
310003, China
Abstract
The separation and identification of bioactive substances that come from natural resources have aroused increasing attention. Momordica charantia (M. charantia) has a variety of bio-activities, containing anti-oxidation, immune regulation, anti-tumor, radiation protection,
anti-diabetes, and liver protection. After the extraction new substances from Momordica charantia, their treatment effect on lung cancer combined with Hedyotis diffusa was determined and the related mechanism was explored as well in this study. Firstly, the CCK-8 assay was conducted
and the inhibition of the new substances combined with Hedyotis diffusa. Next, the real time RT-PCR was conducted and the relative expression of the VEGF in the cancer cells was determined. In addition, the complete chloroplast genome sequence of M. charantia is followed by the
phylogenetic analysis.
Publisher
American Scientific Publishers
Subject
Renewable Energy, Sustainability and the Environment,Biomaterials,Bioengineering